DNA Microarray Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034)
Description
The global DNA microarray market was valued at USD 5.14 Billion in 2024, driven by the rising burden of chronic diseases and the increased applications of DNA microarray technology in clinical diagnostics across the globe. The market is further estimated to grow in the forecast period of 2025-2034 at a CAGR of 10.60% to reach about USD 14.08 Billion by 2034.
DNA Microarray Market Overview
A DNA microarray comprises of an assortment of microscopic DNA spots that are connected to a solid surface. Every individual DNA spot comprises several thousands of copies of a particular sequence of DNA, called probes. It is a tool that is utilized to verify whether the DNA sample provided by a particular individual includes a gene mutation such as BRCA1 or BRCA2. The microarray chip consists of a small glass plate that is wrapped in plastic.
The global DNA microarray market is likely to register robust growth due to the rising investment in research and development across the healthcare industry and rising per-capita healthcare expenditure. The increased adoption of genetic testing along with rapid growth in the healthcare infrastructure is further expected to propel the market growth worldwide. Other factors that influence the market include increased application of DNA microarrays in clinical diagnostics, growing demand for personalized medicine, collaborative research initiatives, and integration of bioinformatics and big data analytics with DNA microarray technology.
DNA Microarray Market Growth Drivers
Increasing Prevalence of Chronic Diseases to Affect the Market Landscape Significantly
The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes, is impacting the market dynamics as microarray technology is widely used to understand and diagnose these diseases. The World Health Organization (WHO) states that 1 out of 5 people is likely to develop cancer in their lifetime. Additionally, it is estimated that more than 35 million new cancer cases will occur in 2050. DNA microarray platforms significantly contribute to advancement in cancer research and play a major role in gene expression analysis and biomarker discovery. Thus, the growing cancer burden propelled by both population aging and growth is projected to boost the market growth.
Growth in Strategic Partnerships to Meet Rising DNA Microarray Market Demand
In July 2023, Spectrum Solutions, a provider of medical and nonmedical contract manufacturing solutions, acquired United States-based biotech firm Microarrays, Inc. which specializes in developing microarray-based assays, as well as a molecular diagnostic laboratory Alimetrix, Inc. Spectrum aims to expand its custom assay and microarray-based products by acquiring Microarrays, Inc. assets and plans to leverage its contract manufacturing and biospecimen collection capabilities to offer a comprehensive suite of services and advance patient care. The rise in such strategic partnerships is anticipated to stimulate innovation and growth in the market.
DNA Microarray Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Rising Demand for Genetic Testing
The market is experiencing a growing interest in consumer genetics and direct-to-consumer (DTC) genetic testing services which is likely to propel the market demand. Additionally, DNA microarrays are finding their application in prenatal testing to detect chromosomal abnormalities and genetic disorders in fetuses, and thus are expected to support market expansion.
Shift Towards Personalized Medicine
The growing demand for personalized medicine, which delivers tailored treatments based on individual genetic profiles, is likely to boost the DNA microarray market value. This technology can help to identify genetic variations that influence disease susceptibility and treatment response and thereby contribute to improving patient outcomes.
Increased Government and Private Funding
One of the major market trends is the increased funding from government agencies and private organizations to advance genomics research. This investment plays a significant role in stimulating the adoption of advanced DNA microarray systems in research institutes and thereby impacts market demand.
Expanding Applications in Clinical Diagnostics
The DNA microarray market is affected by the expanding applications of DNA microarray technology in clinical diagnostics for the detection and diagnosis of genetic disorders, infectious diseases, and cancers. The use of microarray results in rapid and accurate results, leading to early diagnosis and treatment of various diseases.
DNA Microarray Segmentation
The EMR’s report titled “DNA Microarray Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Segmentation Based on DNA Microarray Type is Anticipated to Witness Substantial Growth
Based on type, the market is segmented into complementary DNA microarrays, and oligonucleotide DNA microarrays, among others. The oligonucleotide DNA microarray segment is expected to grow over the coming years due to its ability to identify multiple and novel pathogens within a single test. This DNA microarray type leverages innovative technology that potentially permits swift and cost-effective screens for all possible mutations along with sequence variations in genomic DNA and is expected to witness a significant market demand.
DNA Microarray Market Analysis by Region
Based on the region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to hold a significant market share during the forecast period. This is on account of the presence of key players like Illumina, Inc., and Thermo Fisher Scientific Inc., in the region along with increasing investments in technological advancements in genomics. Surging investments by key players in research and development along with the high prevalence of age-related chronic diseases, are anticipated to fuel the market.
Meanwhile, the Asia Pacific region is anticipated to witness substantial growth in the market. Growing awareness regarding genetic testing and growing funding from the government in the healthcare industry across the region are driving market demand. The Asia Pacific region is providing the largest base for clinical trials and drug discovery along with a growing patient population which is further expected to propel the market growth.
Leading Players in the DNA Microarray Market
The key features of the market report comprise strategic initiatives by the leading key players including patent analysis, fundings and investment analysis, and strategic initiatives by the leading market players. The major companies in the market are as follows:
Illumina, Inc.
Headquartered in California, this American biotechnology company is a leading provider of DNA microarray and sequencing technologies. It has a robust portfolio including Bead-Based Microarray Technology that utilizes silica microbeads.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. offers a range of DNA microarray platforms for use in research and clinical diagnostics and contributes significantly to the DNA microarray market growth. This American-headquartered company actively invests in research and development activities to develop and commercialize advanced products.
Agilent Technologies, Inc.
California-based Agilent Technologies, Inc. is a global leader in laboratory technologies and provides a reliable set of microarray tools for research purposes. The company's microarray platform can be used for postnatal, prenatal, and tumor sample analysis applications.
Arrayit Corporation
This life sciences technology company has a prominent presence in the market. Arrayit Corporation is strengthening its market position by investing in the development of novel microarray technologies and forming strategic collaborations with research institutes.
Other key players in the market include Savyon Diagnostics, SCIENION GmbH, QIAGEN, and PerkinElmer, Inc., among others.
Key Questions Answered in the DNA Microarray Market Report
DNA Microarray Market Overview
A DNA microarray comprises of an assortment of microscopic DNA spots that are connected to a solid surface. Every individual DNA spot comprises several thousands of copies of a particular sequence of DNA, called probes. It is a tool that is utilized to verify whether the DNA sample provided by a particular individual includes a gene mutation such as BRCA1 or BRCA2. The microarray chip consists of a small glass plate that is wrapped in plastic.
The global DNA microarray market is likely to register robust growth due to the rising investment in research and development across the healthcare industry and rising per-capita healthcare expenditure. The increased adoption of genetic testing along with rapid growth in the healthcare infrastructure is further expected to propel the market growth worldwide. Other factors that influence the market include increased application of DNA microarrays in clinical diagnostics, growing demand for personalized medicine, collaborative research initiatives, and integration of bioinformatics and big data analytics with DNA microarray technology.
DNA Microarray Market Growth Drivers
Increasing Prevalence of Chronic Diseases to Affect the Market Landscape Significantly
The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes, is impacting the market dynamics as microarray technology is widely used to understand and diagnose these diseases. The World Health Organization (WHO) states that 1 out of 5 people is likely to develop cancer in their lifetime. Additionally, it is estimated that more than 35 million new cancer cases will occur in 2050. DNA microarray platforms significantly contribute to advancement in cancer research and play a major role in gene expression analysis and biomarker discovery. Thus, the growing cancer burden propelled by both population aging and growth is projected to boost the market growth.
Growth in Strategic Partnerships to Meet Rising DNA Microarray Market Demand
In July 2023, Spectrum Solutions, a provider of medical and nonmedical contract manufacturing solutions, acquired United States-based biotech firm Microarrays, Inc. which specializes in developing microarray-based assays, as well as a molecular diagnostic laboratory Alimetrix, Inc. Spectrum aims to expand its custom assay and microarray-based products by acquiring Microarrays, Inc. assets and plans to leverage its contract manufacturing and biospecimen collection capabilities to offer a comprehensive suite of services and advance patient care. The rise in such strategic partnerships is anticipated to stimulate innovation and growth in the market.
DNA Microarray Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Rising Demand for Genetic Testing
The market is experiencing a growing interest in consumer genetics and direct-to-consumer (DTC) genetic testing services which is likely to propel the market demand. Additionally, DNA microarrays are finding their application in prenatal testing to detect chromosomal abnormalities and genetic disorders in fetuses, and thus are expected to support market expansion.
Shift Towards Personalized Medicine
The growing demand for personalized medicine, which delivers tailored treatments based on individual genetic profiles, is likely to boost the DNA microarray market value. This technology can help to identify genetic variations that influence disease susceptibility and treatment response and thereby contribute to improving patient outcomes.
Increased Government and Private Funding
One of the major market trends is the increased funding from government agencies and private organizations to advance genomics research. This investment plays a significant role in stimulating the adoption of advanced DNA microarray systems in research institutes and thereby impacts market demand.
Expanding Applications in Clinical Diagnostics
The DNA microarray market is affected by the expanding applications of DNA microarray technology in clinical diagnostics for the detection and diagnosis of genetic disorders, infectious diseases, and cancers. The use of microarray results in rapid and accurate results, leading to early diagnosis and treatment of various diseases.
DNA Microarray Segmentation
The EMR’s report titled “DNA Microarray Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Instruments & Reagents
- Consumables
- Software & Services
- Complementary DNA Microarrays
- Oligonucleotide DNA Microarrays
- Others
- Cancer Research
- Drug Discovery and Development
- Gene Expression Analysis
- Diagnostics
- Others
- Biotechnology and Pharmaceutical Industries
- Diagnostic Centres
- Hospitals and Clinics
- Academic and Research Institutes
- Hospitals
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Segmentation Based on DNA Microarray Type is Anticipated to Witness Substantial Growth
Based on type, the market is segmented into complementary DNA microarrays, and oligonucleotide DNA microarrays, among others. The oligonucleotide DNA microarray segment is expected to grow over the coming years due to its ability to identify multiple and novel pathogens within a single test. This DNA microarray type leverages innovative technology that potentially permits swift and cost-effective screens for all possible mutations along with sequence variations in genomic DNA and is expected to witness a significant market demand.
DNA Microarray Market Analysis by Region
Based on the region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to hold a significant market share during the forecast period. This is on account of the presence of key players like Illumina, Inc., and Thermo Fisher Scientific Inc., in the region along with increasing investments in technological advancements in genomics. Surging investments by key players in research and development along with the high prevalence of age-related chronic diseases, are anticipated to fuel the market.
Meanwhile, the Asia Pacific region is anticipated to witness substantial growth in the market. Growing awareness regarding genetic testing and growing funding from the government in the healthcare industry across the region are driving market demand. The Asia Pacific region is providing the largest base for clinical trials and drug discovery along with a growing patient population which is further expected to propel the market growth.
Leading Players in the DNA Microarray Market
The key features of the market report comprise strategic initiatives by the leading key players including patent analysis, fundings and investment analysis, and strategic initiatives by the leading market players. The major companies in the market are as follows:
Illumina, Inc.
Headquartered in California, this American biotechnology company is a leading provider of DNA microarray and sequencing technologies. It has a robust portfolio including Bead-Based Microarray Technology that utilizes silica microbeads.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. offers a range of DNA microarray platforms for use in research and clinical diagnostics and contributes significantly to the DNA microarray market growth. This American-headquartered company actively invests in research and development activities to develop and commercialize advanced products.
Agilent Technologies, Inc.
California-based Agilent Technologies, Inc. is a global leader in laboratory technologies and provides a reliable set of microarray tools for research purposes. The company's microarray platform can be used for postnatal, prenatal, and tumor sample analysis applications.
Arrayit Corporation
This life sciences technology company has a prominent presence in the market. Arrayit Corporation is strengthening its market position by investing in the development of novel microarray technologies and forming strategic collaborations with research institutes.
Other key players in the market include Savyon Diagnostics, SCIENION GmbH, QIAGEN, and PerkinElmer, Inc., among others.
Key Questions Answered in the DNA Microarray Market Report
- What was the global DNA microarray market value in 2024?
- What is the global DNA microarray market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on product type?
- What is the market breakup based on type?
- Who are the major end users in the market?
- Where do DNA microarrays find their application?
- What are the major factors aiding the global DNA microarray market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- How do the prevalence and incidence of chronic diseases affect the market landscape?
- What are the major global DNA microarray market trends?
- How does the rise in the geriatric population impact the market size?
- Which product type will dominate the market share?
- Which application area is expected to have a high market value in the coming years?
- Which DNA microarray type will experience the highest demand in the market segment?
- Which end user is projected to contribute to the highest market growth?
- Who are the key players involved in the DNA microarray market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global DNA Microarray Market Overview
- 3.1 Global DNA Microarray Market Historical Value (2018-2024)
- 3.2 Global DNA Microarray Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global DNA Microarray Market Landscape*
- 5.1 Global DNA Microarray Market: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global DNA Microarray Market: Product Landscape
- 5.2.1 Analysis by Product Type
- 5.2.2 Analysis by Type
- 6 Global DNA Microarray Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global DNA Microarray Market Segmentation (218-2034)
- 7.1 Global DNA Microarray Market (2018-2034) by Product Type
- 7.1.1 Market Overview
- 7.1.2 Instruments & Reagents
- 7.1.3 Consumables
- 7.1.4 Software & Services
- 7.2 Global DNA Microarray Market (2018-2034) by Type
- 7.2.1 Market Overview
- 7.2.2 Complementary DNA Microarrays
- 7.2.3 Oligonucleotide DNA Microarrays
- 7.2.4 Others
- 7.3 Global DNA Microarray Market (2018-2034) by Application
- 7.3.1 Market Overview
- 7.3.2 Cancer Research
- 7.3.3 Drug Discovery and Development
- 7.3.4 Gene Expression Analysis
- 7.3.5 Diagnostics
- 7.3.6 Others
- 7.4 Global DNA Microarray Market (2018-2034) by End User
- 7.4.1 Market Overview
- 7.4.2 Biotechnology and Pharmaceutical Industries
- 7.4.3 Diagnostic Centers
- 7.4.4 Hospitals and Clinics
- 7.4.5 Academic and Research Institutes
- 7.4.6 Hospitals
- 7.4.7 Others
- 7.5 Global DNA Microarray Market (2018-2034) by Region
- 7.5.1 Market Overview
- 7.5.2 North America
- 7.5.3 Europe
- 7.5.4 Asia Pacific
- 7.5.5 Latin America
- 7.5.6 Middle East and Africa
- 8 North America DNA Microarray Market (218-2034)
- 8.1 North America DNA Microarray Market (2018-2034) by Product Type
- 8.1.1 Market Overview
- 8.1.2 Instruments & Reagents
- 8.1.3 Consumables
- 8.1.4 Software & Services
- 8.2 North America DNA Microarray Market (2018-2034) by Type
- 8.2.1 Market Overview
- 8.2.2 Complementary DNA Microarrays
- 8.2.3 Oligonucleotide DNA Microarrays
- 8.2.4 Others
- 8.3 North America DNA Microarray Market (2018-2034) by Application
- 8.3.1 Market Overview
- 8.3.2 Cancer Research
- 8.3.3 Drug Discovery and Development
- 8.3.4 Gene Expression Analysis
- 8.3.5 Diagnostics
- 8.3.6 Others
- 8.4 North America DNA Microarray Market (2018-2034) by End User
- 8.4.1 Market Overview
- 8.4.2 Biotechnology and Pharmaceutical Industries
- 8.4.3 Diagnostic Centers
- 8.4.4 Hospitals and Clinics
- 8.4.5 Academic and Research Institutes
- 8.4.6 Hospitals
- 8.4.7 Others
- 8.5 North America DNA Microarray Market (2018-2034) by Country
- 8.5.1 United States of America
- 8.5.2 Canada
- 9 Europe DNA Microarray Market (218-2034)
- 9.1 Europe DNA Microarray Market (2018-2034) by Product Type
- 9.1.1 Market Overview
- 9.1.2 Instruments & Reagents
- 9.1.3 Consumables
- 9.1.4 Software & Services
- 9.2 Europe DNA Microarray Market (2018-2034) by Type
- 9.2.1 Market Overview
- 9.2.2 Complementary DNA Microarrays
- 9.2.3 Oligonucleotide DNA Microarrays
- 9.2.4 Others
- 9.3 Europe DNA Microarray Market (2018-2034) by Application
- 9.3.1 Market Overview
- 9.3.2 Cancer Research
- 9.3.3 Drug Discovery and Development
- 9.3.4 Gene Expression Analysis
- 9.3.5 Diagnostics
- 9.3.6 Others
- 9.4 Europe DNA Microarray Market (2018-2034) by End User
- 9.4.1 Market Overview
- 9.4.2 Biotechnology and Pharmaceutical Industries
- 9.4.3 Diagnostic Centers
- 9.4.4 Hospitals and Clinics
- 9.4.5 Academic and Research Institutes
- 9.4.6 Hospitals
- 9.4.7 Others
- 9.5 Europe DNA Microarray Market (2018-2034) by Country
- 9.5.1 United Kingdom
- 9.5.2 Germany
- 9.5.3 France
- 9.5.4 Italy
- 9.5.5 Others
- 10 Asia Pacific DNA Microarray Market (218-2034)
- 10.1 Asia Pacific DNA Microarray Market (2018-2034) by Product Type
- 10.1.1 Market Overview
- 10.1.2 Instruments & Reagents
- 10.1.3 Consumables
- 10.1.4 Software & Services
- 10.2 Asia Pacific DNA Microarray Market (2018-2034) by Type
- 10.2.1 Market Overview
- 10.2.2 Complementary DNA Microarrays
- 10.2.3 Oligonucleotide DNA Microarrays
- 10.2.4 Others
- 10.3 Asia Pacific DNA Microarray Market (2018-2034) by Application
- 10.3.1 Market Overview
- 10.3.2 Cancer Research
- 10.3.3 Drug Discovery and Development
- 10.3.4 Gene Expression Analysis
- 10.3.5 Diagnostics
- 10.3.6 Others
- 10.4 Asia Pacific DNA Microarray Market (2018-2034) by End User
- 10.4.1 Market Overview
- 10.4.2 Biotechnology and Pharmaceutical Industries
- 10.4.3 Diagnostic Centers
- 10.4.4 Hospitals and Clinics
- 10.4.5 Academic and Research Institutes
- 10.4.6 Hospitals
- 10.4.7 Others
- 10.5 Asia Pacific DNA Microarray Market (2018-2034) by Country
- 10.5.1 China
- 10.5.2 Japan
- 10.5.3 India
- 10.5.4 ASEAN
- 10.5.5 Australia
- 10.5.6 Others
- 11 Latin America DNA Microarray Market (218-2034)
- 11.1 Latin America DNA Microarray Market (2018-2034) by Product Type
- 11.1.1 Market Overview
- 11.1.2 Instruments & Reagents
- 11.1.3 Consumables
- 11.1.4 Software & Services
- 11.2 Latin America DNA Microarray Market (2018-2034) by Type
- 11.2.1 Market Overview
- 11.2.2 Complementary DNA Microarrays
- 11.2.3 Oligonucleotide DNA Microarrays
- 11.2.4 Others
- 11.3 Latin America DNA Microarray Market (2018-2034) by Application
- 11.3.1 Market Overview
- 11.3.2 Cancer Research
- 11.3.3 Drug Discovery and Development
- 11.3.4 Gene Expression Analysis
- 11.3.5 Diagnostics
- 11.3.6 Others
- 11.4 Latin America DNA Microarray Market (2018-2034) by End User
- 11.4.1 Market Overview
- 11.4.2 Biotechnology and Pharmaceutical Industries
- 11.4.3 Diagnostic Centers
- 11.4.4 Hospitals and Clinics
- 11.4.5 Academic and Research Institutes
- 11.4.6 Hospitals
- 11.4.7 Others
- 11.5 Latin America DNA Microarray Market (2018-2034) by Country
- 11.5.1 Brazil
- 11.5.2 Argentina
- 11.5.3 Mexico
- 11.5.4 Others
- 12 Middle East and Africa DNA Microarray Market (218-2034)
- 12.1 Middle East and Africa DNA Microarray Market (2018-2034) by Product Type
- 12.1.1 Market Overview
- 12.1.2 Instruments & Reagents
- 12.1.3 Consumables
- 12.1.4 Software & Services
- 12.2 Middle East and Africa DNA Microarray Market (2018-2034) by Type
- 12.2.1 Market Overview
- 12.2.2 Complementary DNA Microarrays
- 12.2.3 Oligonucleotide DNA Microarrays
- 12.2.4 Others
- 12.3 Middle East and Africa DNA Microarray Market (2018-2034) by Application
- 12.3.1 Market Overview
- 12.3.2 Cancer Research
- 12.3.3 Drug Discovery and Development
- 12.3.4 Gene Expression Analysis
- 12.3.5 Diagnostics
- 12.3.6 Others
- 12.4 Middle East and Africa DNA Microarray Market (2018-2034) by End User
- 12.4.1 Market Overview
- 12.4.2 Biotechnology and Pharmaceutical Industries
- 12.4.3 Diagnostic Centers
- 12.4.4 Hospitals and Clinics
- 12.4.5 Academic and Research Institutes
- 12.4.6 Hospitals
- 12.4.7 Others
- 12.5 Middle East and Africa DNA Microarray Market (2018-2034) by Country
- 12.5.1 Saudi Arabia
- 12.5.2 United Arab Emirates
- 12.5.3 Nigeria
- 12.5.4 South Africa
- 12.5.5 Others
- 13 Regulatory Framework
- 13.1 Regulatory Overview
- 13.2 US FDA
- 13.3 EU EMA
- 13.4 INDIA CDSCO
- 13.5 JAPAN PMDA
- 13.6 Others
- 14 Patent Analysis
- 14.1 Analysis by Type of Patent
- 14.2 Analysis by Publication Year
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Patent Age
- 14.5 Analysis by CPC Analysis
- 14.6 Analysis by Patent Valuation
- 14.7 Analysis by Key Players
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Strategic Initiatives
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership and Collaborations
- 16.3 Analysis by Joint Ventures
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Geography
- 17 Strategic Initiatives
- 17.1 Analysis by Partnership Instances
- 17.2 Analysis by Type of Partnership and Collaborations
- 17.3 Analysis by Joint Ventures
- 17.4 Analysis by Leading Players
- 17.5 Analysis by Geography
- 18 Supplier Landscape
- 18.1 Market Share Analysis, By Region (Top 5 Companies)
- 18.1.1 Market Share Analysis: Global
- 18.1.2 Market Share Analysis: North America
- 18.1.3 Market Share Analysis: Europe
- 18.1.4 Market Share Analysis: Asia-Pacific
- 18.1.5 Market Share Analysis: Others
- 18.2 Illumina, Inc.
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Company News and Developments
- 18.2.5 Certifications
- 18.3 Thermo Fisher Scientific Inc.
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Company News and Developments
- 18.3.5 Certifications
- 18.4 Agilent Technologies, Inc.
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Company News and Developments
- 18.4.5 Certifications
- 18.5 Arrayit Corporation
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Company News and Developments
- 18.5.5 Certifications
- 18.6 Savyon Diagnostics
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Company News and Developments
- 18.6.5 Certifications
- 18.7 SCIENION GmbH
- 18.7.1 Financial Analysis
- 18.7.2 Product Portfolio
- 18.7.3 Demographic Reach and Achievements
- 18.7.4 Company News and Developments
- 18.7.5 Certifications
- 18.8 QIAGEN
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Company News and Developments
- 18.8.5 Certifications
- 18.9 PerkinElmer, Inc.
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Company News and Developments
- 18.9.5 Certifications
- 19 Global DNA Microarray Market – Distribution Model (Additional Insight)
- 19.1 Overview
- 19.2 Potential Distributors
- 19.3 Key Parameters for Distribution Partner Assessment
- 20 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
